AdAlta Limited (1AD.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0860-0.0030 (-3.37%)
At close: 2:08PM AEDT
| Previous close | 0.0890 |
| Open | 0.0890 |
| Bid | 0.0870 x 25215400 |
| Ask | 0.0880 x 5549800 |
| Day's range | 0.0860 - 0.0890 |
| 52-week range | 0.0800 - 0.2650 |
| Volume | 170,384 |
| Avg. volume | 498,751 |
| Market cap | 21.085M |
| Beta (5Y monthly) | 1.04 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0240 |
| Earnings date | 26 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
ASX Announcement: AdAlta and Carina Biotech to develop next-generation CAR-T cancer therapeutics
AdAlta Limited (ASX:1AD) and Carina Biotech Pty Ltd have entered a collaboration agreement to develop next-generation i-body enabled CAR-T cells, with the potential to bring CAR-T cell therapy to treat a far greater range of cancers than the small number of blood cancers that has been achieved today.
- Simply Wall St.
We're Hopeful That AdAlta (ASX:1AD) Will Use Its Cash Wisely
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
© 2021 Verizon Media. All rights reserved.
